These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 29696584)

  • 1. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
    Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
    Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations.
    Maselli RA; Wei DT; Hodgson TS; Sampson JB; Vazquez J; Smith HL; Pytel P; Ferns M
    Muscle Nerve; 2021 Aug; 64(2):219-224. PubMed ID: 34037996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome.
    Chaudhry V; Watson DF; Bird SJ; Cornblath DR
    Muscle Nerve; 1991 Dec; 14(12):1227-30. PubMed ID: 1662773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Suzuki S
    Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recessive congenital myasthenic syndrome caused by a homozygous mutation in SYT2 altering a highly conserved C-terminal amino acid sequence.
    Maselli RA; van der Linden H; Ferns M
    Am J Med Genet A; 2020 Jul; 182(7):1744-1749. PubMed ID: 32250532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Electrophysiology of Presynaptic Congenital Myasthenic Syndromes With and Without Facilitation: From Electrodiagnostic Findings to Molecular Mechanisms.
    Nicolau S; Milone M
    Front Neurol; 2019; 10():257. PubMed ID: 30941097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5.
    Maselli RA; Arredondo J; Vázquez J; Chong JX; Bamshad MJ; Nickerson DA; Lara M; Ng F; Lo VL; Pytel P; McDonald CM
    Ann N Y Acad Sci; 2018 Feb; 1413(1):119-125. PubMed ID: 29377152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.
    Hülsbrink R; Hashemolhosseini S
    Clin Neurophysiol; 2014 Dec; 125(12):2328-36. PubMed ID: 25065299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.
    Oh SJ; Kurokawa K; Claussen GC; Ryan HF
    Muscle Nerve; 2005 Oct; 32(4):515-20. PubMed ID: 16003742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian recommendations for Lambert-Eaton myasthenic syndrome (LEMS) management.
    Evoli A; Liguori R; Romani A; Mantegazza R; Di Muzio A; Giometto B; Pegoraro E; Rodolico C; Vigliani MC;
    Neurol Sci; 2014 Apr; 35(4):515-20. PubMed ID: 24481713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological evaluation of the neuromuscular junction: a brief review.
    Kouyoumdjian JA; Estephan EP
    Arq Neuropsiquiatr; 2023 Dec; 81(12):1040-1052. PubMed ID: 38157872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Child neurology: diagnosis of Lambert-Eaton myasthenic syndrome in children.
    Morgan-Followell B; de Los Reyes E
    Neurology; 2013 May; 80(21):e220-2. PubMed ID: 23690300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Miralles F
    Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism.
    Gable KL; Massey JM
    Semin Neurol; 2015 Aug; 35(4):340-6. PubMed ID: 26502758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis Lambert-Eaton overlap syndrome.
    Oh SJ
    Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteins synaptotagmin and syntaxin are not general targets of Lambert-Eaton myasthenic syndrome autoantibody.
    Hajela RK; Atchison WD
    J Neurochem; 1995 Mar; 64(3):1245-51. PubMed ID: 7861157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
    Honnorat J
    Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.